Tavşan, E. And Erin, N. 2016. NK2 receptor but not NK1 receptor antagonist (GR159897, RP67580) increases release of angiogenic chemokine from breast carcinoma.. 7th European Congress of Pharmacology , (İstanbul, Turkey).

Tavşan, E., & Erin, N., (2016). NK2 receptor but not NK1 receptor antagonist (GR159897, RP67580) increases release of angiogenic chemokine from breast carcinoma. . 7th European Congress of Pharmacology, İstanbul, Turkey

Tavşan, ESRA, And NURAY ERİN. "NK2 receptor but not NK1 receptor antagonist (GR159897, RP67580) increases release of angiogenic chemokine from breast carcinoma.," 7th European Congress of Pharmacology, İstanbul, Turkey, 2016

Tavşan, ESRA And Erin, NURAY. "NK2 receptor but not NK1 receptor antagonist (GR159897, RP67580) increases release of angiogenic chemokine from breast carcinoma.." 7th European Congress of Pharmacology , İstanbul, Turkey, 2016

Tavşan, E. And Erin, N. (2016) . "NK2 receptor but not NK1 receptor antagonist (GR159897, RP67580) increases release of angiogenic chemokine from breast carcinoma.." 7th European Congress of Pharmacology , İstanbul, Turkey.

@conferencepaper{conferencepaper, author={ESRA TAVŞAN And author={NURAY ERİN}, title={NK2 receptor but not NK1 receptor antagonist (GR159897, RP67580) increases release of angiogenic chemokine from breast carcinoma.}, congress name={7th European Congress of Pharmacology}, city={İstanbul}, country={Turkey}, year={2016}}